Dr Aigli Evryviadou obtained a BSc in Biology from the University of Bath, UK in 2013. Her final year project during her bachelor degree involved induction of mouse embryonic pancreatic cells to hepatocytes by glucocorticoid treatment (supervised by David Tosh). Aigli was later awarded an MSc in Molecular Medicine from Imperial College London, UK in 2015. During her master studies, Aigli investigated the interaction between von Willebrand factor and the platelet membrane receptor TREML1and its role in haemostasis and thrombosis in the laboratory of Tom McKinnon. Aigli next pursued doctoral studies at the University of Birmingham, UK in the laboratory of Ed Rainger, where she investigated the role of platelet-derived extracellular vesicles in regulating the inflammatory action of monocytes in atherosclerosis and graduated with a PhD in Cardiovascular Science in 2019. Aigli is currently a postdoc in the Skourides lab where she studies mucociliary clearance in vitro.